Literature DB >> 19833746

Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome.

Lars Morawietz1, Lorena Martinez-Gamboa, Sonja Scheffler, Gert Hausdorf, Anja Dankof, Ulrike Kuckelkorn, Thomas Doerner, Karl Egerer, Gerd-R Burmester, Denise L Faustman, Eugen Feist.   

Abstract

OBJECTIVE: Minor salivary gland specimens were analyzed to investigate dysregulation of the proteasome system in patients with Sjögren's syndrome (SS) and patients with sicca syndrome.
METHODS: Labial biopsy specimens from 17 patients with SS and 11 patients with non-autoimmunesicca syndrome were analyzed by immunohistochemistry for expression of the inducible proteasomal subunits ss1i, ss2i, and ss5i. The infiltrating subsets of lymphocytes were characterized using immunofluorescence stainings against the cell-surface markers CD20 and CD27. Two-dimensional electrophoresis and immunoblotting were used for detection of the proteasomal subunits ss1 and ss1i in peripheral blood monocyte cells. Gene expression of the constitutive subunits ss1, ss2, and ss5 and the corresponding inducible subunits ss1i, ss2i, and ss5i was further investigated at the mRNA level in small lip biopsies using real-time polymerase chain reaction.
RESULTS: The expression of ss1i in infiltrating and peripheral immune cells was altered in patients with SS compared to patients with non-autoimmune sicca syndrome and healthy controls. No significant differences were found in ss2i and ss5i expression between the same groups in small lip biopsies. Chisholm-Mason grade and ss1i expression were found to be inversely correlated (Spearman r = -0.461, p = 0.014). The phenotype and distribution of the lymphocytic infiltrate showed no differences between patients with primary and secondary SS regardless of ss1i expression.
CONCLUSION: The proteasomal ss1i subunit is dysregulated in peripheral white blood cells and in inflammatory infiltrates of minor salivary glands in patients with SS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833746     DOI: 10.3899/jrheum.081098

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

Review 1.  Proteasome inhibitors as experimental therapeutics of autoimmune diseases.

Authors:  Sue Ellen Verbrugge; Rik J Scheper; Willem F Lems; Tanja D de Gruijl; Gerrit Jansen
Journal:  Arthritis Res Ther       Date:  2015-01-28       Impact factor: 5.156

2.  Pharmacodynamic monitoring of (immuno)proteasome inhibition during bortezomib treatment of a critically ill patient with lupus nephritis and myocarditis.

Authors:  Karina A de Groot; Michel Tsang A Sjoe; Denise Niewerth; Jacqueline Cloos; Jonathan L Blank; Hans W M Niessen; Sonja Zweegman; Alexandre E Voskuyl; Gerrit Jansen; Joost W van der Heijden
Journal:  Lupus Sci Med       Date:  2015-12-18

3.  Shared and Unique Patterns of DNA Methylation in Systemic Lupus Erythematosus and Primary Sjögren's Syndrome.

Authors:  Juliana Imgenberg-Kreuz; Jonas Carlsson Almlöf; Dag Leonard; Christopher Sjöwall; Ann-Christine Syvänen; Lars Rönnblom; Johanna K Sandling; Gunnel Nordmark
Journal:  Front Immunol       Date:  2019-07-30       Impact factor: 7.561

4.  Interferon-γ induces immunoproteasomes and the presentation of MHC I-associated peptides on human salivary gland cells.

Authors:  Martha E Arellano-Garcia; Kaori Misuno; Simon D Tran; Shen Hu
Journal:  PLoS One       Date:  2014-08-07       Impact factor: 3.240

5.  Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ.

Authors:  Khetam Ghannam; Lorena Martinez-Gamboa; Lydia Spengler; Sabine Krause; Biljana Smiljanovic; Marc Bonin; Salyan Bhattarai; Andreas Grützkau; Gerd-R Burmester; Thomas Häupl; Eugen Feist
Journal:  PLoS One       Date:  2014-08-06       Impact factor: 3.240

6.  The Combined Deficiency of Immunoproteasome Subunits Affects Both the Magnitude and Quality of Pathogen- and Genetic Vaccination-Induced CD8+ T Cell Responses to the Human Protozoan Parasite Trypanosoma cruzi.

Authors:  Jonatan Ersching; José R Vasconcelos; Camila P Ferreira; Braulia C Caetano; Alexandre V Machado; Oscar Bruna-Romero; Monique A Baron; Ludmila R P Ferreira; Edécio Cunha-Neto; Kenneth L Rock; Ricardo T Gazzinelli; Maurício M Rodrigues
Journal:  PLoS Pathog       Date:  2016-04-29       Impact factor: 6.823

7.  Response to abatacept is associated with the inhibition of proteasome β1i expression in T cells of patients with rheumatoid arthritis.

Authors:  Khetam Ghannam; Lorena Martinez Gamboa; Claudia Kedor; Lydia Spengler; Ulrike Kuckelkorn; Thomas Häupl; Gerd Burmester; Eugen Feist
Journal:  RMD Open       Date:  2020-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.